Birmingham, West Midlands -- (SBWIRE) -- 12/09/2013 -- Value Penny Stocks issues special report on Newcastle Investment Corp. (NYSE:NCT), SeaChange International (NASDAQ:SEAC), Unilife Corp (NASDAQ:UNIS), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX).
Newcastle Investment Corp. (NYSE:NCT) opened its last trade at the price of $5.31. Its closing price was $5.43 after gaining 1.69% for the day. The company traded with the total volume of 2,631,203 shares, while its average trading volume remained 5.06 million shares. The beta of this stock stands at 3.25. Newcastle Investment Corp. operates as a real estate investment and finance company in the United States. The company invests in and manages a portfolio consisting of real estate securities; loans; excess mortgage servicing rights; and real estate related assets, such as senior living facilities, and other assets.
For How Long NCT will Fight for Profitability? Read This Trend Analysis report
SeaChange International (NASDAQ:SEAC) percentage change plunged -16.46% to close at $12.03 with the total traded volume of 2,602,449D shares, along with average volume of 315,695.00 shares. The 52 week range of the stock remained $9.10 - $15.25, while its day lowest price was $11.60. The share price hit the day highest price of $12.59. SeaChange International, Inc. provides multi-screen video products and services that facilitate the aggregation, licensing, management, and distribution of video, television programming, and advertising content to cable system operators, telecommunications companies, broadcast television companies, and mobile communications providers worldwide.
Has SEAC Found The Bottom And Ready To Gain Momentum? Find Out Here
Unilife Corp (NASDAQ:UNIS) traded on volume of 2,601,126 shares in the last session against average volume of 2.70 million shares. The company started its trading session with the price of $4.45 and closed at $4.31 by scoring -4.22%. Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs.
Why Should Investors Buy UNIS After the Recent Fall? Just Go Here and Find Out
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) started its last trading session with the price of $6.07 and closed at $5.93 by scoring -1.98%. The stock traded with total volume of 2,579,839 shares, while the average trading volume remained 888,747.00 shares. The beta value of this stock stands at 3.03. Day range for the stock was $5.63 - $6.17. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop small molecule pharmaceuticals through the structure-guided drug design process.
Will BCRX Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)